These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8452366)

  • 1. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine.
    Balzarini J; Holy A; Jindrich J; Naesens L; Snoeck R; Schols D; De Clercq E
    Antimicrob Agents Chemother; 1993 Feb; 37(2):332-8. PubMed ID: 8452366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo.
    Balzarini J; Holy A; Jindrich J; Dvorakova H; Hao Z; Snoeck R; Herdewijn P; Johns DG; De Clercq E
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4961-5. PubMed ID: 1711214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newborn NMRI mice.
    Balzarini J; Vahlenkamp T; Egberink H; Hartmann K; Witvrouw M; Pannecouque C; Casara P; Navé JF; De Clercq E
    Antimicrob Agents Chemother; 1997 Mar; 41(3):611-6. PubMed ID: 9056002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems.
    Balzarini J; Aquaro S; Perno CF; Witvrouw M; Holý A; De Clercq E
    Biochem Biophys Res Commun; 1996 Feb; 219(2):337-41. PubMed ID: 8604988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
    Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S
    J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunobiological activity of N-[2-(phosphonomethoxy)alkyl] derivatives of N6-substituted adenines, and 2,6-diaminopurines.
    Zídek Z; Potmesil P; Kmoníèková E; Holý A
    Eur J Pharmacol; 2003 Aug; 475(1-3):149-59. PubMed ID: 12954371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyclic nucleotide analogs derived from 8-azapurines: synthesis and antiviral activity.
    Holý A; Dvoráková H; Jindrich J; Masojídková M; Budĕsínský M; Balzarini J; Andrei G; De Clercq E
    J Med Chem; 1996 Sep; 39(20):4073-88. PubMed ID: 8831773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2',3'-dideoxyinosine and 2',3'-dideoxy-2,6-diaminopurine riboside.
    Balzarini J; Naesens L; Robins MJ; De Clercq E
    J Acquir Immune Defic Syndr (1988); 1990; 3(12):1140-7. PubMed ID: 2123003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity.
    Balzarini J; Pannecouque C; Naesens L; Andrei G; Snoeck R; De Clercq E; Hocková D; Holý A
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1321-7. PubMed ID: 15571252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines.
    Balzarini J; Schols D; Van Laethem K; De Clercq E; Hocková D; Masojidkova M; Holý A
    J Antimicrob Chemother; 2007 Jan; 59(1):80-6. PubMed ID: 17124193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
    De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytostatic activity of antiviral acyclic nucleoside phosphonates in rodent lymphocytes.
    Zídek Z; Potmesil P; Holý A
    Toxicol Appl Pharmacol; 2003 Nov; 192(3):246-53. PubMed ID: 14575642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines.
    De Clercq E; Sakuma T; Baba M; Pauwels R; Balzarini J; Rosenberg I; Holý A
    Antiviral Res; 1987 Dec; 8(5-6):261-72. PubMed ID: 3451698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
    Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
    Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of antiretroviral chemokines by human cells cultured with acyclic nucleoside phosphonates.
    Zídek Z; Kmonícková E; Holý A
    Eur J Pharmacol; 2007 Nov; 574(1):77-84. PubMed ID: 17716649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activity of N9-[3-fluoro-2-(phosphonomethoxy)propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurines.
    Baszczyňski O; Jansa P; Dračínský M; Klepetářová B; Holý A; Votruba I; de Clercq E; Balzarini J; Janeba Z
    Bioorg Med Chem; 2011 Apr; 19(7):2114-24. PubMed ID: 21429755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent.
    Balzarini J; Naesens L; Herdewijn P; Rosenberg I; Holy A; Pauwels R; Baba M; Johns DG; De Clercq E
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):332-6. PubMed ID: 2911579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory properties of antiviral acyclic nucleotide analogues: cytokine stimulatory and nitric oxide costimulatory effects.
    Zídek Z; Holý A; Franková D
    Int J Immunopharmacol; 1997; 19(9-10):587-97. PubMed ID: 9637359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivo.
    Naesens L; Balzarini J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):53-64. PubMed ID: 1776876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
    Naesens L; Balzarini J; Bischofberger N; De Clercq E
    Antimicrob Agents Chemother; 1996 Jan; 40(1):22-8. PubMed ID: 8787873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.